<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0008336.ref061">
 <label>61</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kupperman</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Lee</surname>
   <given-names>EC</given-names>
  </name>, 
  <name>
   <surname>Cao</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Bannerman</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Fitzgerald</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Berger</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer</article-title>. 
  <source>Cancer Res</source>. 
  <year>2010</year>;
  <volume>70</volume>(
  <issue>5</issue>):
  <fpage>1970</fpage>â€“
  <lpage>80</lpage>. 
  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-2766</pub-id>
  <?supplied-pmid 20160034?>
  <pub-id pub-id-type="pmid">20160034</pub-id>
 </mixed-citation>
</ref>
